Mary-Ann Xavier - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Biomolecules|August 27, 2021

BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma MultiformeMary-Ann Xavier, Fernando Rezende, Ricardo Titze-de-Almeida, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018

PET Imaging of PARP Expression Using 18F-OlaparibThomas C Wilson, Mary-Ann Xavier, James Knight, et al.

Biorxiv : the Preprint Server for Biology|May 15, 2024

Crystallographic Fragment Screen of Coxsackievirus A16 2A Protease identifies new opportunities for the development of broad-spectrum anti-enteroviralsRyan M Lithgo, Charles W E Tomlinson, Michael Fairhead, et al.

Nature Communications|October 8, 2025

Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Biomolecules|August 27, 2021

BRCAness as a Biomarker of Susceptibility to PARP Inhibitors in Glioblastoma MultiformeMary-Ann Xavier, Fernando Rezende, Ricardo Titze-de-Almeida, et al.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 4, 2018

PET Imaging of PARP Expression Using 18F-OlaparibThomas C Wilson, Mary-Ann Xavier, James Knight, et al.

Biorxiv : the Preprint Server for Biology|May 15, 2024

Crystallographic Fragment Screen of Coxsackievirus A16 2A Protease identifies new opportunities for the development of broad-spectrum anti-enteroviralsRyan M Lithgo, Charles W E Tomlinson, Michael Fairhead, et al.

Nature Communications|October 8, 2025

Combined crystallographic fragment screening and deep mutational scanning enable discovery of Zika virus NS2B-NS3 protease inhibitorsXiaomin Ni, R Blake Richardson, Andre Schutzer Godoy, et al.

Pageof 1